• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】18455

【品名】3-hydroxy-4-methoxybenzaldehyde; Isovanillin

【CA登记号】621-59-0

【 分 子 式 】C8H8O3

【 分 子 量 】152.14972

【元素组成】C 63.15% H 5.3% O 31.55%

与该中间体有关的原料药合成路线共 19 条

合成路线1

该中间体在本合成路线中的序号:(I)

The alkylation of isovanillin (I) with cyclopentyl bromide (II) and K2CO3 in DMF gives 3-(cyclopentyloxy)-4-methoxybenzaldehyde (III), which is methylated with MeLi in THF yielding the 1-phenylethanol (IV). The oxidation of (IV) with pyridinium dichromate (PDC) in dichloromethane affords the corresponding acetophenone (V), which is treated with NH2OH in pyridine to afford the oxime (VI). Finally, this oxime is treated with NaOCN and TFA in dichloromethane, or with chlorosulfonyl isocyanate in THF.

1 Lombardo, L.J. (American Home Products Corp.); Oxime-carbamates and oxime-carbonates as bronchodilators and anti-inflammatory agents. EP 0470805; GB 2246777; JP 1992253945; US 5124455 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 18455 3-hydroxy-4-methoxybenzaldehyde; Isovanillin 621-59-0 C8H8O3 详情 详情
(II) 10972 1-Bromocyclopentane; Cyclopentyl bromide 137-43-9 C5H9Br 详情 详情
(III) 16510 3-(cyclopentyloxy)-4-methoxybenzaldehyde C13H16O3 详情 详情
(IV) 37969 1-[3-(cyclopentyloxy)-4-methoxyphenyl]-1-ethanol C14H20O3 详情 详情
(V) 37970 1-[3-(cyclopentyloxy)-4-methoxyphenyl]-1-ethanone C14H18O3 详情 详情
(VI) 37971 1-[3-(cyclopentyloxy)-4-methoxyphenyl]-1-ethanone oxime C14H19NO3 详情 详情

合成路线2

该中间体在本合成路线中的序号:(I)

The alkylation of isovanillin (I) with cyclopentyl bromide (II) by means of K2CO3 in refluxing ethanol (or hot DMF) gives the 4-cyclopentyloxy-3-methoxybenzaldehyde (III), which is oxidized with H2O2 and NaOH (or NaClO2 in AcOH/water) yielding the carboxylic acid (IV). The reaction of (IV) with SOCl2 and DMF in refluxing toluene affords the acyl chloride (V), which is finally condensed with 3,5-dichloropyridine-4-amine (VI) by means of potassium tert-butoxide in toluene or NaH in THF or by heating at the melting point. The intermediate 3,5-dichloropyridine-4-amine (VI) is obtained by chlorination of pyridine-4-amine (VII) with HCl and H2O2 at 70 C.

1 Ashton, M.J.; Cook, D.C.; Fenton, G.; Hills, S.J.; Mcfarlane, I.M.; Palfreyman, M.N.; Ratcliffe, A.J.; Vicker, N. (Aventis Pharma SA); Benzamides. EP 0497564; EP 0569414; JP 1994504782; WO 9212961 .
2 Cook, D.C.; Walton, J.B.; Pemberton, C.; Jones, R.H.; McFarlane, I.M.; Thompson, D.M.; Thatcher, A.A.; Kabir, H.; Lythgoe, D.J.; Process development of the PDE IV inhibitor 3-(cyclopentyloxy)-N-(3,5-dichloropyrid-4-yl)-4-methoxybenzamide. Org Process Res Dev 1998, 2, 3, 157.
3 Ashton, M.J.; et al.; Selective type IV phosphodiesterase inhibitors as antiasthmatic agents. The syntheses and biological activities of 3-(cyclopentyloxy)-4-methoxybenzamides and analogues. J Med Chem 1994, 37, 11, 1696.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 18455 3-hydroxy-4-methoxybenzaldehyde; Isovanillin 621-59-0 C8H8O3 详情 详情
(II) 10972 1-Bromocyclopentane; Cyclopentyl bromide 137-43-9 C5H9Br 详情 详情
(III) 16510 3-(cyclopentyloxy)-4-methoxybenzaldehyde C13H16O3 详情 详情
(IV) 33214 3-(cyclopentyloxy)-4-methoxybenzoic acid C13H16O4 详情 详情
(V) 33213 3-(cyclopentyloxy)benzoyl chloride C12H13ClO2 详情 详情
(VI) 25135 3,5-dichloro-4-pyridinamine; 4-amino-3,5-dichloropyridine 22889-78-7 C5H4Cl2N2 详情 详情
(VII) 25661 4-pyridinamine; 4-aminopyridine 5044-74-5 C5H6N2 详情 详情

合成路线3

该中间体在本合成路线中的序号:(I)

Isovanillin (I) was alkylated with phenethyl bromide (II) in the presence of K2CO3 to afford phenethyl ether (III). The aldehyde function of (III) was then reduced with NaBH4, and the resulting alcohol (IV) was converted to chloride (V) by means of SOCl2 in THF-DMF. Subsequent displacement of the chlorine atom of (V) by KCN afforded nitrile (VI), which was hydrolyzed to acid (VII) with KOH in aqueous EtOH. Further conversion of (VII) to acid chloride (VIII), followed by condensation with dipropyl amine (IX) in toluene provided amide (X). Finally, reduction with LiAlH4 gave the corresponding amine, that was isolated as the hydrochloride salt.

1 Nakazato, A.; et al.; Design, synthesis, structure-activity relationship. J Med Chem 1999, 42, 6, 1076.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 18455 3-hydroxy-4-methoxybenzaldehyde; Isovanillin 621-59-0 C8H8O3 详情 详情
(II) 20730 1-(2-bromoethyl)benzene;1-Bromo-2-phenylethane;(2-Bromoethyl)benzene;Phenethyl bromide 103-63-9 C8H9Br 详情 详情
(III) 23679 4-methoxy-3-(phenethyloxy)benzaldehyde C16H16O3 详情 详情
(IV) 23680 [4-methoxy-3-(phenethyloxy)phenyl]methanol C16H18O3 详情 详情
(V) 23681 4-(chloromethyl)-1-methoxy-2-(phenethyloxy)benzene; 5-(chloromethyl)-2-methoxyphenyl phenethyl ether C16H17ClO2 详情 详情
(VI) 23682 2-[4-methoxy-3-(phenethyloxy)phenyl]acetonitrile C17H17NO2 详情 详情
(VII) 23683 2-[4-methoxy-3-(phenethyloxy)phenyl]acetic acid C17H18O4 详情 详情
(VIII) 23685 2-[4-methoxy-3-(phenethyloxy)phenyl]acetyl chloride C17H17ClO3 详情 详情
(IX) 21856 N,N-dipropylamine; N-propyl-1-propanamine 142-84-7 C6H15N 详情 详情
(X) 23686 2-[4-methoxy-3-(phenethyloxy)phenyl]-N,N-dipropylacetamide C23H31NO3 详情 详情

合成路线4

该中间体在本合成路线中的序号:(I)

Isovanillin (I) is an available starting material to obtain 3-cyclopentyloxy-4-methoxybenzaldehyde (II), which is converted into the corresponding oxime (III) by treatment with hydroxylamine hydrochloride / sodium acetate trihydrate and NaHCO3. The oxime (III) is reduced to benzylamine (IV) by means hydrogen gas and catalyzed by Raney-Nickel. The reaction of benzylamine (IV) with carbon disulfide and ethyl chloroformate gives the corresponding benzyl isothiocyanate (V), which is converted into thiourea (VI) by means ammonia solution. The cyclization of thiourea (VI) with potasium tert-butoxide and ethyl cyanoacetate yields the corresponding 2-thiouracil (VII), which is converted into 5-nitroso derivative (VIII) by treatment with acetic acid and sodium nitrite solution. The hydrogenation of 5-nitroso-uracil (VIII) with hydrogen gas and neutral Raney-nickel gives diaminouracil compound (IX), which is converted into the isobutyrilaminouracil derivative (XI) by means NaHCO3 and isobutyric anhydride (X). Compound (XI) is refluxed in NaOH to afford 2-thioxantine (XII), which is converted into 2,6-dithioxantine (XIII) by means phosphorus pentasulfide in pyridine. Finally, the reaction of compound (XIII) with ethylamine gives the 2-thioisoguanine (XIV), which is desulfurized by neutral Raney-Nickel and converted into the desired purine hydrochloride by means hydrochloric acid.

1 Cavalla, D.; Hoefer, P.; Gehrig, A.; Wintergest, P. (Euroceltique SA); Novel chemical cpds. having PDE-IV inhibition activity. EP 0705265; JP 1997500376; US 5939422; WO 9500516 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 18455 3-hydroxy-4-methoxybenzaldehyde; Isovanillin 621-59-0 C8H8O3 详情 详情
(II) 16510 3-(cyclopentyloxy)-4-methoxybenzaldehyde C13H16O3 详情 详情
(III) 19176 3-(cyclopentyloxy)-4-methoxybenzaldehyde oxime C13H17NO3 详情 详情
(IV) 19177 3-(cyclopentyloxy)-4-methoxybenzylamine; [3-(cyclopentyloxy)-4-methoxyphenyl]methanamine C13H19NO2 详情 详情
(V) 19178 3-(cyclopentyloxy)-4-methoxybenzyl isothiocyanate; 2-(cyclopentyloxy)-4-(isothiocyanatomethyl)-1-methoxybenzene C14H17NO2S 详情 详情
(VI) 19179 N-[3-(cyclopentyloxy)-4-methoxybenzyl]thiourea C14H20N2O2S 详情 详情
(VII) 19180 6-amino-1-[3-(cyclopentyloxy)-4-methoxybenzyl]-2-thioxo-2,3-dihydro-4(1H)-pyrimidinone C17H21N3O3S 详情 详情
(VIII) 19181 6-amino-1-[3-(cyclopentyloxy)-4-methoxybenzyl]-5-nitroso-2-thioxo-2,3-dihydro-4(1H)-pyrimidinone C17H20N4O4S 详情 详情
(IX) 19182 5,6-diamino-1-[3-(cyclopentyloxy)-4-methoxybenzyl]-2-thioxo-2,3-dihydro-4(1H)-pyrimidinone C17H22N4O3S 详情 详情
(X) 19183 2-methylbutyric anhydride 1468-39-9 C10H18O3 详情 详情
(XI) 19184 N-[6-amino-1-[3-(cyclopentyloxy)-4-methoxybenzyl]-4-oxo-2-thioxo-1,2,3,4-tetrahydro-5-pyrimidinyl]-2-methylpropanamide C21H28N4O4S 详情 详情
(XII) 19185 3-[3-(cyclopentyloxy)-4-methoxybenzyl]-8-isopropyl-2-thioxo-1,2,3,7-tetrahydro-6H-purin-6-one C21H26N4O3S 详情 详情
(XIII) 19186 3-[3-(cyclopentyloxy)-4-methoxybenzyl]-8-isopropyl-3,7-dihydro-1H-purine-2,6-dithione C21H26N4O2S2 详情 详情
(XIV) 19187 3-[3-(cyclopentyloxy)-4-methoxybenzyl]-6-(ethylamino)-8-isopropyl-3,7-dihydro-2H-purine-2-thione C23H31N5O2S 详情 详情

合成路线5

该中间体在本合成路线中的序号:(I)

The reaction of isovanillin with hydroxylamine sulfate and NaOH in refluxing ethanol/water gives the corresponding oxime (II), which is reduced with Raney-Ni and NaOH in the same solvent yielding the benzylamine (III). The protection of the amino group of (III) with benzyloxycarbonyl chloride affords the carbamate (IV), which is condensed with ethyl bromoacetate (IV) by means of K2CO3 in refluxing 2-butanone to give the ester (VI). The hydrolysis of (VI) with NaOH in hot methanol/water yields the corresponding acid (VII), which is condensed with 1-benzylpiperazine (VIII) by means of ethyl chloroformate in THF to afford the piperazide (IX). The deprotection of the amino group of (IX) with H2 over Pd/C in hot ethanol gives the benzylamine (X), which is finally condensed with 4,5-dichloropyridazin-3(2H)-one (XI) by means of triethylamine in refluxing ethanol/water.

1 Tanikawa, K.; Saito, A.; Hirotsuka, M.; Shikada, K. (Nissan Chemical Industry, Ltd.); Pyridazinone derivs. with pharmaceutical activity. EP 0706517; JP 1996041033; US 5728702; US 5929074; WO 9501343 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
10101 Benzyloxycarbonyl chloride; Benzyl chloroformate; 1-[[(Chlorocarbonyl)oxy]methyl]benzene 501-53-1 C8H7ClO2 详情 详情
(I) 18455 3-hydroxy-4-methoxybenzaldehyde; Isovanillin 621-59-0 C8H8O3 详情 详情
(II) 30957 2-methoxy-5-[(methylimino)methyl]phenol C9H11NO2 详情 详情
(III) 30958 5-(aminomethyl)-2-methoxyphenol C8H11NO2 详情 详情
(IV) 30959 benzyl 3-hydroxy-4-methoxybenzylcarbamate C16H17NO4 详情 详情
(V) 16640 Ethyl 2-bromoacetate; Ethyl bromoacetate 105-36-2 C4H7BrO2 详情 详情
(VI) 30960 ethyl 2-[5-([[(benzyloxy)carbonyl]amino]methyl)-2-methoxyphenoxy]acetate C20H23NO6 详情 详情
(VII) 30961 2-[5-([[(benzyloxy)carbonyl]amino]methyl)-2-methoxyphenoxy]acetic acid C18H19NO6 详情 详情
(VIII) 28542 N-Benzylpiperazine; 1-Benzylpiperazine 2759-28-6 C11H16N2 详情 详情
(IX) 30962 benzyl 3-[2-(4-benzyl-1-piperazinyl)-2-oxoethoxy]-4-methoxybenzylcarbamate C29H33N3O5 详情 详情
(X) 30963 2-[5-(aminomethyl)-2-methoxyphenoxy]-1-(4-benzyl-1-piperazinyl)-1-ethanone C21H27N3O3 详情 详情
(XI) 24750 Bis(isopropylamine)dichloro platinum complex C6H18Cl2N2Pt 详情 详情

合成路线6

该中间体在本合成路线中的序号:(XII)

In a different synthetic strategy, the required dibromostyrene (XIV) was prepared in low yield by Wittig-like condensation of 3-hydroxy-4-methoxybenzaldehyde (XII) with carbon tetrabromide in the presence of PPh-3. In an improved process, the phenolic hydroxyl of (XII) was first protected as the silyl ether (X), which was then condensed with CBr4/PPh3 to give (XIII). Subsequent desilylation of (XIII) with tetrabutylammonium fluoride provided (XIV). Stereoselective debromination of the dibromostyrene (XIV) with tributyltin hydride and tetrakis(triphenylphosphine)palladium(0) led to the Z-bromostyrene (XV). This was finally subjected to a palladium-catalyzed Suzuki coupling with 3,4,5-trimethoxybenzeneboronic acid (XVI) to furnish the title Z-olefin as the major isomer

1 Gaukroger, K.; Hadfield, J.A.; Hepworth, L.A.; Lawrence, N.J.; McGrown, A.T.; Novel synthesis of cis and trans isomers of combretastatin A-4. J Org Chem 2001, 66, 24, 8135.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 60505 2-methoxy-5-[(Z)-2-(3,4,5-trimethoxyphenyl)ethenyl]phenol 117048-60-9 C18H20O5 详情 详情
(X) 26114 3-[[tert-butyl(dimethyl)silyl]oxy]-4-methoxybenzaldehyde C14H22O3Si 详情 详情
(XII) 18455 3-hydroxy-4-methoxybenzaldehyde; Isovanillin 621-59-0 C8H8O3 详情 详情
(XIII) 60509 tert-butyl(dimethyl)silyl 5-(2,2-dibromovinyl)-2-methoxyphenyl ether; tert-butyl[5-(2,2-dibromovinyl)-2-methoxyphenoxy]dimethylsilane C15H22Br2O2Si 详情 详情
(XIV) 60510 5-(2,2-dibromovinyl)-2-methoxyphenol C9H8Br2O2 详情 详情
(XV) 60511 5-[(Z)-2-bromoethenyl]-2-methoxyphenol C9H9BrO2 详情 详情
(XVI) 60512 3,4,5-trimethoxyphenylboronic acid C9H13BO5 详情 详情

合成路线7

该中间体在本合成路线中的序号:(XII)

A further synthetic strategy was based on the Perkin condensation between 3,4,5-trimethoxyphenylacetic acid (XVII) and 3-hydroxy-4-methoxybenzaldehyde (XII). Decarboxylation of the resultant phenylcinnamic acid (XVIII) by heating with copper powder in quinoline furnished the desired stilbene, accompanied by only minor amounts of the corresponding E-isomer

1 Gaukroger, K.; Hadfield, J.A.; Hepworth, L.A.; Lawrence, N.J.; McGrown, A.T.; Novel synthesis of cis and trans isomers of combretastatin A-4. J Org Chem 2001, 66, 24, 8135.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 60505 2-methoxy-5-[(Z)-2-(3,4,5-trimethoxyphenyl)ethenyl]phenol 117048-60-9 C18H20O5 详情 详情
(XII) 18455 3-hydroxy-4-methoxybenzaldehyde; Isovanillin 621-59-0 C8H8O3 详情 详情
(XVII) 25349 2-(3,4,5-trimethoxyphenyl)acetic acid 937-52-0 C11H14O5 详情 详情
(XVIII) 60513 (E)-3-(3-hydroxy-4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)-2-propenoic acid C19H20O7 详情 详情

合成路线8

该中间体在本合成路线中的序号:(IV)

Addition of ethylmagnesium bromide to 3,4,5-trimethoxybenzaldehyde (I) gave secondary alcohol (II), which was converted into ketone (III) by Swern oxidation with DMSO and oxalyl chloride. Piperidinium acetate-catalyzed aldol condensation of propiophenone (III) with 3-hydroxy-4-methoxybenzaldehyde (IV), with water removal over 4 Å molecular sieves, gave the corresponding chalcone, obtained as a mixture of geometric isomers, from which the major E-isomer was separated by column chromatography.

1 Ducki, S.; Forrest, R.; Hadfield, J.A.; Kendall, A.; Lawrence, N.J.; McGown, A.T.; Rennison, D.; Potent antimitotic and cell growth inhibitory properties of substituted chalcones. Bioorg Med Chem Lett 1998, 8, 9, 1051.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 11136 3,4,5-Trimethoxybenzaldehyde 86-81-7 C10H12O4 详情 详情
(II) 18453 1-(3,4,5-trimethoxyphenyl)-1-propanol C12H18O4 详情 详情
(III) 18454 1-(3,4,5-trimethoxyphenyl)-1-propanone C12H16O4 详情 详情
(IV) 18455 3-hydroxy-4-methoxybenzaldehyde; Isovanillin 621-59-0 C8H8O3 详情 详情

合成路线9

该中间体在本合成路线中的序号:(I)

Coupling of isovanillin (I) with 3-hydroxytetrahyrofuran (II) in the presence of triphenyl phosphine and diisopropyl azodicarboxylate yielded the tetrahydrofuryl ether (III). Subsequent oxidation of the aldehyde using sodium chlorite and sulfamic acid gave carboxylic acid (IV), which was further converted to acid chloride (V) upon treatment with SOCl2 in toluene. Finally, condensation of (V) with 4-amino-3,5-dimethylisoxazole (VI) provided the title compound.

1 Tober, C.; Rundfeldt, C.; Rostock, A.; Bartsch, R.; Nickel, B.; Szeleny, I.; Herbst, M.; Dieter, R.; Olbrich, A.; Kutscher, B.; Sauer, W.; Jainta, H.; Jahn, W.; Engel, J.; D-23129. Drugs Fut 1995, 20, 11, 1112.
2 Fenton, G.; Palfreyman, M.N.; Thurairatnam, S. (Aventis Pharma SA); Substd. aromatic cpds. as cAMP phosphodiesterase- and TNF-inhibitors. EP 0741707; JP 1997509654; WO 9520578 .
3 Dieter, H.-R.; Engel, J.; Kutscher, B.; Polymeropoulos, E.; Szelenyi, S.; Nickel, B. (Asta Medica AG); Novel 1,2,4-Triaminobenzene derivs. and process for their preparation. DE 4200259; EP 0554543; JP 1993345752; US 5384330 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 18455 3-hydroxy-4-methoxybenzaldehyde; Isovanillin 621-59-0 C8H8O3 详情 详情
(II) 20619 tetrahydro-3-furanol 453-20-3 C4H8O2 详情 详情
(III) 20620 4-methoxy-3-(tetrahydro-3-furanyloxy)benzaldehyde C12H14O4 详情 详情
(IV) 20621 4-methoxy-3-(tetrahydro-3-furanyloxy)benzoic acid C12H14O5 详情 详情
(V) 20622 4-methoxy-3-(tetrahydro-3-furanyloxy)benzoyl chloride C12H13ClO4 详情 详情
(VI) 20623 3,5-dimethyl-4-isoxazolamine; 3,5-dimethyl-4-isoxazolylamine C5H8N2O 详情 详情

合成路线10

该中间体在本合成路线中的序号:(I)

Isovanillin (I) was protected as the silyl ether (II) and subsequently reduced to the benzyl alcohol (III). After conversion of (III) to bromide (IV), its reaction with triphenylphosphine gave phosphonium bromide (V). The ylide resulting from deprotonation of (V) with n-butyllithium was then condensed with 3,4,5-trimethoxybenzaldehyde (VI) to afford the required E-stilbene (VII) along with the corresponding Z-isomer, which were separated by column chromatography. Asymmetric Sharpless dihydroxylation of (VII) by means of AD mix-alpha provided the (1S,2S)-diol (VIII). Finally, desilylation of (VIII) using tetrabutylammonium fluoride afforded the target phenol.

1 Pettit, G.R.; Singh, S.B.; Boyd, M.R.; Hamel, E.; Pettit, R.K.; Schmidt, J.M.; Hogan, F.; Antineoplastic agents. 291. Isolation and synthesis of combretastatins A-4, A-5, and A-6. J Med Chem 1995, 38, 10, 1666.
2 Pettit, G.R.; et al.; Antineoplastic agents. 410. Asymmetric hydroxylation of trans-combretastatin A-4. J Med Chem 1999, 42, 8, 1459.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 18455 3-hydroxy-4-methoxybenzaldehyde; Isovanillin 621-59-0 C8H8O3 详情 详情
(II) 26114 3-[[tert-butyl(dimethyl)silyl]oxy]-4-methoxybenzaldehyde C14H22O3Si 详情 详情
(III) 26115 (3-[[tert-butyl(dimethyl)silyl]oxy]-4-methoxyphenyl)methanol C14H24O3Si 详情 详情
(IV) 26116 4-(bromomethyl)-2-[[tert-butyl(dimethyl)silyl]oxy]phenyl methyl ether; [5-(bromomethyl)-2-methoxyphenoxy](tert-butyl)dimethylsilane C14H23BrO2Si 详情 详情
(V) 26117 (3-[[tert-butyl(dimethyl)silyl]oxy]-4-methoxybenzyl)(triphenyl)phosphonium bromide C32H38BrO2PSi 详情 详情
(VI) 11136 3,4,5-Trimethoxybenzaldehyde 86-81-7 C10H12O4 详情 详情
(VII) 26118 tert-butyl[2-methoxy-5-[(E)-2-(3,4,5-trimethoxyphenyl)ethenyl]phenoxy]dimethylsilane; tert-butyl(dimethyl)silyl 2-methoxy-5-[(E)-2-(3,4,5-trimethoxyphenyl)ethenyl]phenyl ether C24H34O5Si 详情 详情
(VIII) 26119 (1S,2S)-1-(3-[[tert-butyl(dimethyl)silyl]oxy]-4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)-1,2-ethanediol C24H36O7Si 详情 详情

合成路线11

该中间体在本合成路线中的序号:(I)

3-Hydroxy-4-methoxy-2-nitrobenzaldehyde (II) was prepared by nitration of isovanillin (I) with fuming nitric acid in cold HOAc. Subsequent alkylation of the phenolic hydroxyl of (II) with n-pentyl bromide yielded the corresponding pentyl ether (III). The nitro group of (III) was then reduced to amine (IV) employing tin chloride in EtOH. Condensation of amino aldehyde (IV) with dimethyl malonate under Knoevenagel conditions furnished the quinolinone derivative (V). Saponification of the ester group of (V), followed by activation of the resultant carboxylic acid (VI) with SOCl2, gave rise to the acid chloride (VII). This was then coupled with 3,4-(methylenedioxy)benzylamine (VIII) to provide the target amide.

1 Inaba, T.; Kaya, T.; Iwamura, H. (Japan Tobacco Inc.); 2-Oxoquinoline cpds. and medicinal uses thereof. EP 1142877; JP 2000256323; WO 0040562 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 18455 3-hydroxy-4-methoxybenzaldehyde; Isovanillin 621-59-0 C8H8O3 详情 详情
(II) 56017 3-Hydroxy-4-methoxy-2-nitrobenzaldehyde 6284-92-0 C8H7NO5 详情 详情
(III) 56018 4-methoxy-2-nitro-3-(pentyloxy)benzaldehyde C13H17NO5 详情 详情
(IV) 56019 2-amino-4-methoxy-3-(pentyloxy)benzaldehyde C13H19NO3 详情 详情
(V) 56020 methyl 7-methoxy-2-oxo-8-(pentyloxy)-1,2-dihydro-3-quinolinecarboxylate C17H21NO5 详情 详情
(VI) 56021 7-methoxy-2-oxo-8-(pentyloxy)-1,2-dihydro-3-quinolinecarboxylic acid C16H19NO5 详情 详情
(VII) 56022 7-methoxy-2-oxo-8-(pentyloxy)-1,2-dihydro-3-quinolinecarbonyl chloride C16H18ClNO4 详情 详情
(VIII) 33669 1,3-benzodioxol-5-ylmethylamine; 1,3-benzodioxol-5-ylmethanamine; 3,4-Methylendioxybenzylamine 2620-50-0 C8H9NO2 详情 详情

合成路线12

该中间体在本合成路线中的序号:(I)

Isovanillin (I) was protected as the allyl ether (III) by treatment with allyl bromide (II) and K2CO3. Aldehyde reduction of (III) with NaBH4 gave alcohol (IV), which was converted to chloride (V) using SOCl2. Condensation of chloride (V) with the sodium salt of 3,4,5-trimethoxyphenol (VI) produced the corresponding ether (VII). Finally, deprotection of the allyl group of (VII) was achieved by treatment with Wilkinson’s catalyst and DABCO.

1 McGown, A.T.; Hadfield, J.A.; Rennison, D.; Woo, M.; Lawrence, N.J.; Antimitotic and cell growth inhibitory properties of combrestastatin A-4-like ethers. Bioorg Med Chem Lett 2001, 11, 1, 51.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 18455 3-hydroxy-4-methoxybenzaldehyde; Isovanillin 621-59-0 C8H8O3 详情 详情
(II) 11463 3-Bromo-1-propene; 3-Bromopropene;allyl bromide 106-95-6 C3H5Br 详情 详情
(III) 48348 3-Allyloxy-4-methoxybenzaldehyde C11H12O3 详情 详情
(IV) 48349 [3-(allyloxy)-4-methoxyphenyl]methanol C11H14O3 详情 详情
(V) 48350 allyl 5-(chloromethyl)-2-methoxyphenyl ether; 2-(allyloxy)-4-(chloromethyl)-1-methoxybenzene C11H13ClO2 详情 详情
(VI) 37163 3,4,5-trimethoxyphenol C9H12O4 详情 详情
(VII) 48351 allyl 2-methoxy-5-[(3,4,5-trimethoxyphenoxy)methyl]phenyl ether; 5-[[3-(allyloxy)-4-methoxybenzyl]oxy]-1,2,3-trimethoxybenzene C20H24O6 详情 详情

合成路线13

该中间体在本合成路线中的序号:(XI)

In an alternative procedure, isovanillin (XI) was protected by O-benzylation, giving (XII), and its aldehyde group was subsequently reduced to alcohol (XIII) with NaBH4. The benzylic alcohol (XIII) was chlorinated to (XIV), which was converted to nitrile (XV) by chloride displacement with tetraethylammonium cyanide. Nitrile (XV) was subjected to Claisen condensation with ethyl formate, yielding (XVI), followed by sulfonylation with benzenesulfonyl chloride to afford (XVII), which was cyclized to the amino thiophene (XVIII) by treatment with ethyl thioglycolate (IV) as above. Condensation of (XVIII) with 2,5-dimethoxytetrahydrofuran (VI) produced the corresponding pyrrole derivative (XIX). After conversion of the ester group of (XIX) to amide (XX) upon heating with pyrrolidine (VIII), its cyclization with POCl3 furnished the thienopyrrolizinone (XXI). The O-benzyl protecting group of (XXI) was finally cleaved by treatment with HBr in HOAc.

1 Lisowski, V.; et al.; Design, synthesis and antiproliferative activity of tripentones: A new series of antitubulin agents. Bioorg Med Chem Lett 2001, 11, 16, 2205.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(IV) 18838 methyl 2-sulfanylacetate 2365-48-2 C3H6O2S 详情 详情
(VI) 12121 (Z)-4-(Dimethylamino)-3-imidazo[1,2-a]pyridin-6-yl-3-buten-2-one C13H15N3O 详情 详情
(VIII) 11376 Pyrrolidine 123-75-1 C4H9N 详情 详情
(XI) 18455 3-hydroxy-4-methoxybenzaldehyde; Isovanillin 621-59-0 C8H8O3 详情 详情
(XII) 10966 3-(Benzyloxy)-4-methoxybenzaldehyde; 3-Benzyloxy-4-methoxybenzaldehyde 6346-05-0 C15H14O3 详情 详情
(XIII) 23823 5-[4-hydroxy-2-(3-hydroxybutyl)-3,5,6-trimethylphenoxy]-2,2-dimethylpentanoic acid C20H32O5 详情 详情
(XIV) 52232 benzyl 5-(chloromethyl)-2-methoxyphenyl ether; 2-(benzyloxy)-4-(chloromethyl)-1-methoxybenzene C15H15ClO2 详情 详情
(XV) 52233 (3-Benzyloxy-4-methoxyphenyl)acetonitrile C16H15NO2 详情 详情
(XVI) 52234 sodium (Z)-2-[3-(benzyloxy)-4-methoxyphenyl]-2-cyano-1-ethenolate C17H14NNaO3 详情 详情
(XVII) 52235 (Z)-2-[3-(benzyloxy)-4-methoxyphenyl]-2-cyanoethenyl benzenesulfonate C23H19NO5S 详情 详情
(XVIII) 52236 methyl 3-amino-4-[3-(benzyloxy)-4-methoxyphenyl]-2-thiophenecarboxylate C20H19NO4S 详情 详情
(XIX) 52234 sodium (Z)-2-[3-(benzyloxy)-4-methoxyphenyl]-2-cyano-1-ethenolate C17H14NNaO3 详情 详情
(XX) 52238 [4-[3-(benzyloxy)-4-methoxyphenyl]-3-(1H-pyrrol-1-yl)-2-thienyl](1-pyrrolidinyl)methanone C27H26N2O3S 详情 详情
(XXI) 52239 3-[3-(benzyloxy)-4-methoxyphenyl]-8H-thieno[2,3-b]pyrrolizin-8-one C23H17NO3S 详情 详情

合成路线14

该中间体在本合成路线中的序号:(I)

Alkylation of isovanillin (I) with 2-indanyl tosylate (II) produces the corresponding indanyl ether (III). Subsequent reduction of the aldehyde function of (III) with NaBH4 yields the benzylic alcohol (IV), which is converted to chloride (V) by treatment with SOCl2. Displacement of chloride (V) by KCN in hot DMF gives nitrile (VI). The phenylacetonitrile (VI) is then converted to the homologous phenylpropionitrile derivative (VII) by alkylation with iodomethane in the presence of LDA. Further cyano group reduction in (VII) by hydrogenation over Raney Ni provides amine (VIII). Condensation of amine (VIII) with diphenyl N-cyanocarbonimidate affords the N-cyano isourea (IX) which, after reaction with 2,2-dimethoxyethylamine (X), yields the cyano guanidine (XI). Finally, cyclization of (XI) under acidic conditions gives rise to the target 2-(cyanoimino)imidazole derivative.

1 Diaz, A.; Andres, J.I.; Alonso, J.M.; et al.; Synthesis and biological evaluation of imidazol-2-one and 2-cyanoiminoimidazole derivatives: Novel series of PDE4 inhibitors. Bioorg Med Chem Lett 2002, 12, 4, 653.
2 Freyne, E.J.E.; Fernandez-Gadea, F.J.; Andres-Gil, J.I. (Janssen Pharmaceutica NV); PDE IV inhibiting 2-cyanoiminoimidazole derivs.. WO 9814432 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 18455 3-hydroxy-4-methoxybenzaldehyde; Isovanillin 621-59-0 C8H8O3 详情 详情
(II) 57734 2-Indanyl p-toluenesulphonate 17783-69-6 C16H16O3S 详情 详情
(III) 57735 3-(2,3-dihydro-1H-inden-2-yloxy)-4-methoxybenzaldehyde C17H16O3 详情 详情
(IV) 57736 [3-(2,3-dihydro-1H-inden-2-yloxy)-4-methoxyphenyl]methanol C17H18O3 详情 详情
(V) 57737 2-[5-(chloromethyl)-2-methoxyphenoxy]indane; 4-(chloromethyl)-2-(2,3-dihydro-1H-inden-2-yloxy)phenyl methyl ether C17H17ClO2 详情 详情
(VI) 57738 2-[3-(2,3-dihydro-1H-inden-2-yloxy)-4-methoxyphenyl]acetonitrile C18H17NO2 详情 详情
(VII) 57739 2-[3-(2,3-dihydro-1H-inden-2-yloxy)-4-methoxyphenyl]propanenitrile C19H19NO2 详情 详情
(VIII) 57740 2-[3-(2,3-dihydro-1H-inden-2-yloxy)-4-methoxyphenyl]-1-propanamine; 2-[3-(2,3-dihydro-1H-inden-2-yloxy)-4-methoxyphenyl]propylamine C19H23NO2 详情 详情
(IX) 57741 2-[5-(2-{[(cyanoimino)(phenoxy)methyl]amino}-1-methylethyl)-2-methoxyphenoxy]indane C27H27N3O3 详情 详情
(X) 34158 aminoacetaldehyde dimethylacetal; 2,2-dimethoxy-1-ethanamine; 2,2-dimethoxyethylamine 22483-09-6 C4H11NO2 详情 详情
(XI) 57742 N''-cyano-N-{2-[3-(2,3-dihydro-1H-inden-2-yloxy)-4-methoxyphenyl]propyl}-N'-(2,2-dimethoxyethyl)guanidine C25H32N4O4 详情 详情

合成路线15

该中间体在本合成路线中的序号:(XI)

In a related strategy, the precursor di-tert-butyl combretastatin A-4 phosphate (Va) is prepared by protection of isovanillin (XI) as the corresponding imine (XII) with butylamine and p-toluenesulfonic acid, followed by phosphitylation with di-tert-butyl N,N-diethylphosphoramidite in the presence of tetrazole, and oxidation to phosphate (XIII) with m-chloroperbenzoic acid. Subsequent Wittig reaction of aldehyde (XIII) with 3,4,5-trimethoxybenzyl triphenylphosphonium bromide (VIII) produces the target stilbene phosphate derivative (Va) (6). Scheme 3.

6 Griffin, R.J., Quarterman, C.P., Rathbone, D.L., Slack, J.A. (Aston Molecules Ltd.). Substd. diphenylethylenes and analogues of derivs. thereof. WO 9216486.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(Va) 65528     C26H37O8P 详情 详情
(VIII) 19866 triphenyl(3,4,5-trimethoxybenzyl)phosphonium bromide C28H28BrO3P 详情 详情
(XI) 18455 3-hydroxy-4-methoxybenzaldehyde; Isovanillin 621-59-0 C8H8O3 详情 详情
(XII) 65532     C12H17NO2 详情 详情
(XIII) 65533     C16H25O5P 详情 详情

合成路线16

该中间体在本合成路线中的序号:(I)

 

1 Welham MJ.2005.Process for the manufacture。gefitinib. W0 2005023783(本专利为AstraZeneca plc所有)
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 18455 3-hydroxy-4-methoxybenzaldehyde; Isovanillin 621-59-0 C8H8O3 详情 详情
(II) 54574 3-hydroxy-4-methoxybenzonitrile 52805-46-6 C8H7NO2 详情 详情
(III) 66433 4-methoxy-3-(3-morpholinopropoxy)benzonitrile   C15H20N2O3 详情 详情
(IV) 66434 4-methoxy-5-(3-morpholinopropoxy)-2-nitrobenzonitrile 675126-26-8 C15H19N3O5 详情 详情
(V) 66435 2-amino-4-methoxy-5-(3-morpholinopropoxy)benzonitrile 675126-27-9 C15H21N3O3 详情 详情
(VI) 66436 (E)-N,N'-bis(3-chloro-4-fluorophenyl)formimidamide   C13H8Cl2F2N2 详情 详情

合成路线17

该中间体在本合成路线中的序号:(I)

 

1 Jyothi Prasad R. 2005. An improved process for the preparation of gefitinib. WO2005023783(本专利为Natco Pharma Ltd所有)
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 18455 3-hydroxy-4-methoxybenzaldehyde; Isovanillin 621-59-0 C8H8O3 详情 详情
(II) 66437 4-methoxy-3-(3-morpholinopropoxy)benzaldehyde 861453-11-4 C15H21NO4 详情 详情
(III) 66438 4-methoxy-5-(3-morpholinopropoxy)-2-nitrobenzaldehyde   C15H20N2O6 详情 详情
(IV) 66439 (Z)-4-methoxy-5-(3-morpholinopropoxy)-2-nitrobenzaldehyde oxime   C15H21N3O6 详情 详情
(V) 66434 4-methoxy-5-(3-morpholinopropoxy)-2-nitrobenzonitrile 675126-26-8 C15H19N3O5 详情 详情
(VI) 66440 4-methoxy-5-(3-morpholinopropoxy)-2-nitrobenzamide   C15H21N3O6 详情 详情
(VII) 66441 2-amino-4-methoxy-5-(3-morpholinopropoxy)benzamide   C15H23N3O4 详情 详情
(VIII) 66442 7-methoxy-6-(3-morpholinopropoxy)quinazolin-4(3H)-one   C16H21N3O4 详情 详情
(IX) 66443 4-(3-((4-chloro-7-methoxyquinazolin-6-yl)oxy)propyl)morpholine   C16H20ClN3O3 详情 详情
(X) 18688 3-Chloro-4-fluorophenylamine; 3-Chloro-4-fluoroaniline 367-21-5 C6H5ClFN 详情 详情

合成路线18

该中间体在本合成路线中的序号:(I)

 

1 Chandregowda V,Rao GV, Reddy GC. 2007. One-pot conversion of 2-nitrobenzonitriles to quinazolin-4(3H)-ones and synthesis of gefitinib and erlotinib hydrochloride. Heterocycles,71(1): 39~48
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 18455 3-hydroxy-4-methoxybenzaldehyde; Isovanillin 621-59-0 C8H8O3 详情 详情
(II) 18691 4-(3-chloropropyl)morpholine;N-(3-Chloropropyl)morpholine 7357-67-7 C7H14ClNO 详情 详情
(III) 66437 4-methoxy-3-(3-morpholinopropoxy)benzaldehyde 861453-11-4 C15H21NO4 详情 详情
(IV) 66444 (Z)-4-methoxy-3-(3-morpholinopropoxy)benzaldehyde oxime   C15H22N2O4 详情 详情
(V) 66433 4-methoxy-3-(3-morpholinopropoxy)benzonitrile   C15H20N2O3 详情 详情
(VI) 66434 4-methoxy-5-(3-morpholinopropoxy)-2-nitrobenzonitrile 675126-26-8 C15H19N3O5 详情 详情
(VII) 66445 7-methoxy-6-(3-morpholinopropoxy)quinazolin-4(1H)-one   C16H21N3O4 详情 详情
(VIII) 18688 3-Chloro-4-fluorophenylamine; 3-Chloro-4-fluoroaniline 367-21-5 C6H5ClFN 详情 详情

合成路线19

该中间体在本合成路线中的序号:(I)

 

1 Dorg H, Zhang ZL, Huang JH, et al. 2005. Practical synthesisi of an orally active renin inhibitory aliskiren. Tetrahedron Lett, 46(37): 6337~6340
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(XXV) 67017 2-cyano-2-methylpropanamide 7505-93-3 C5H8N2O 详情 详情
(I) 18455 3-hydroxy-4-methoxybenzaldehyde; Isovanillin 621-59-0 C8H8O3 详情 详情
(II) 67010 3-methoxypropyl methanesulfonate   C5H12O4S 详情 详情
(III) 61620 4-Methoxy-3-(3-methoxypropoxy)benzaldehyde 172900-75-3 C12H16O4 详情 详情
(IV) 28116 [4-methoxy-3-(3-methoxypropoxy)phenyl]methanol 172900-74-2 C12H18O4 详情 详情
(V) 28117 3-[5-(bromomethyl)-2-methoxyphenoxy]propyl methyl ether 172900-73-1 C12H17BrO3 详情 详情
(VI) 28131 (4S)-4-benzyl-3-(3-methylbutanoyl)-1,3-oxazolidin-2-one C15H19NO3 详情 详情
(VII) 28118 (4S)-4-benzyl-3-[(2R)-2-[4-methoxy-3-(3-methoxypropoxy)benzyl]-3-methylbutanoyl]-1,3-oxazolidin-2-one C27H35NO6 详情 详情
(VIII) 28119 (2R)-2-[4-methoxy-3-(3-methoxypropoxy)benzyl]-3-methylbutyric acid C17H26O5 详情 详情
(IX) 50573 (2R)-2-[4-methoxy-3-(3-methoxypropoxy)benzyl]-3-methyl-1-butanol C17H28O4 详情 详情
(X) 28120 3-[5-[(2R)-2-(bromomethyl)-3-methylbutyl]-2-methoxyphenoxy]propyl methyl ether 172900-69-5 C17H27BrO3 详情 详情
(XI) 67009 (S)-3,6-diethoxy-2-isopropyl-2,5-dihydropyrazine 134870-62-5 C11H20N2O2 详情 详情
(XII) 67011 3,6-diethoxy-2-isopropyl-5-(2-(4-methoxy-3-(3-methoxypropoxy)benzyl)-3-methylbutyl)-2,5-dihydropyrazine   C28H46N2O5 详情 详情
(XIII) 67012 ethyl 2-amino-4-(4-methoxy-3-(3-methoxypropoxy)benzyl)-5-methylhexanoate   C21H35NO5 详情 详情
(XIV) 28122 methyl (2S,4S)-2-[(tert-butoxycarbonyl)amino]-4-[4-methoxy-3-(3-methoxypropoxy)benzyl]-5-methylhexanoate C25H41NO7 详情 详情
(XV) 67013 tert-butyl (1-hydroxy-4-(4-methoxy-3-(3-methoxypropoxy)benzyl)-5-methylhexan-2-yl)carbamate   C24H41NO6 详情 详情
(XVI) 28123 tert-butyl (1S,3S)-1-formyl-3-[4-methoxy-3-(3-methoxypropoxy)benzyl]-4-methylpentylcarbamate C24H39NO6 详情 详情
(XVII) 18710 Benzyl alcohol; Phenylmethanol 100-51-6 C7H8O 详情 详情
(XVIII) 14560 Benzyl chloromethyl ether; 1-[(chloromethoxy)methyl]benzene 3587-60-8 C8H9ClO 详情 详情
(XIX) 23285 (4R)-4-benzyl-3-(3-methylbutanoyl)-1,3-oxazolidin-2-one C15H19NO3 详情 详情
(XX) 67014 4-benzyl-3-(2-((benzyloxy)methyl)-3-methylbutanoyl)oxazolidin-2-one   C23H27NO4 详情 详情
(XXI) 67015 (R)-2-((benzyloxy)methyl)-3-methylbutanoic acid   C13H18O3 详情 详情
(XXII) 67016 2-((benzyloxy)methyl)-3-methylbutan-1-ol   C13H20O2 详情 详情
(XXIII) 66991 (R)-((2-(bromomethyl)-3-methylbutoxy)methyl)benzene   C13H19BrO 详情 详情
(XXIV) 12122 Cyanoacetamide; 2-Cyanoacetamide 107-91-5 C3H4N2O 详情 详情
(XXVI) 67018 benzyl (3-amino-2,2-dimethyl-3-oxopropyl)carbamate   C13H18N2O3 详情 详情
(XXVII) 28129 3-amino-2,2-dimethylpropanamide 324763-51-1 C5H12N2O 详情 详情
(XXVIII) 28125 tert-butyl (1S,4S)-4-[(benzyloxy)methyl]-2-hydroxy-1-[(2S)-2-[4-methoxy-3-(3-methoxypropoxy)benzyl]-3-methylbutyl]-5-methylhexylcarbamate C37H59NO7 详情 详情
(XXIX) 67019 tert-butyl (6-hydroxy-8-(hydroxymethyl)-3-(4-methoxy-3-(3-methoxypropoxy)benzyl)-2,9-dimethyldecan-5-yl)carbamate   C30H53NO7 详情 详情
(XXX) 67004 tert-butyl (1-(4-isopropyl-5-oxotetrahydrofuran-2-yl)-3-(4-methoxy-3-(3-methoxypropoxy)benzyl)-4-methylpentyl)carbamate   C30H49NO7 详情 详情
(XXXI) 67020 tert-butyl (8-((1-amino-2-methyl-1-oxopropan-2-yl)carbamoyl)-6-hydroxy-3-(4-methoxy-3-(3-methoxypropoxy)benzyl)-2,9-dimethyldecan-5-yl)carbamate   C34H59N3O8 详情 详情
Extended Information